免疫球蛋白在自身免疫性大疱病的研究进展

Abstract

Abstract:

Yu Ling, Feng Suying Department of Dermatology, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing 210042, China Corresponding author: Feng Suying, Email: fengsuying@medmail.com.cn 【Abstract】 As one of active immune effector molecules, immunoglobulins play an important role in the pathogenesis, diagnosis and treatment of autoimmune bullous diseases. Human immunoglobulins can be divided into 5 categories, including IgG, IgA, IgM, IgD and IgE, and all of them participate in and play different roles in the pathogenesis of autoimmune bullous diseases except IgD. IgG can induce the formation of blisters by activating complements and leukocytes as well as by releasing proteolytic enzymes, and different subtypes of IgG differ in biological activities. IgA can cause granulocyte migration and lead to the formation of blisters and pustules. IgE is associated with urticaria-like erythema and eosinophil infiltration. IgM is usually seen in Brazilian pemphigus foliaceus. These findings may provide new ideas for the diagnosis and treatment of autoimmune bullous diseases.

References ［26］

［1］	Gual A, Guilabert A, Iranzo P, et al. IgG autoantibody subclass analysis as a tool to differentiate epidermolysis bullosa acquisita with overlapping features of bullous systemic lupus erythematosus［J］. J Am Acad Dermatol, 2013, 69（1）: e34⁃e36. DOI: 10.1016/j.jaad.2013.01.025.
［2］	Patton T, Plunkett RW, Beutner EH, et al. IgG4 as the predominant IgG subclass in pemphigoides gestationis［J］. J Cutan Pathol, 2006, 33（4）: 299⁃302. DOI: 10.1111/j.0303⁃6987.2006.00458.x.
［3］	Dhandha MM, Seiffert⁃Sinha K, Sinha AA. Specific immunog⁃lobulin isotypes correlate with disease activity, morphology, duration and HLA association in Pemphigus vulgaris［J］. Autoimmunity, 2012, 45（7）: 516⁃526. DOI: 10.3109/08916934. 2012.702811.
［4］	Futei Y, Amagai M, Hashimoto T, et al. Conformational epitope mapping and IgG subclass distribution of desmoglein 3 in paraneoplastic pemphigus［J］. J Am Acad Dermatol, 2003, 49（6）: 1023⁃1028. DOI: 10.1016/S0190⁃9622（03）02160⁃1.
［5］	Recke A, Sitaru C, Vidarsson G, et al. Pathogenicity of IgG subclass autoantibodies to type VII collagen: induction of dermal⁃epidermal separation［J］. J Autoimmun, 2010, 34（4）: 435⁃444. DOI: 10.1016/j.jaut.2009.11.003.
［6］	Mihai S, Chiriac MT, Herrero⁃González J E, et al. IgG4 autoanti⁃bodies induce dermal⁃epidermal separation［J］. Journal of Cellular and Molecular Medicine, 2007, 11（5）: 1117⁃1128. DOI: 10.1111/j.1582⁃4934.2007.00081.x.
［7］	Lane N, Parekh P. IgG/IgA pemphigus［J］. Am J Dermatopathol, 2014, 36（12）: 1002⁃1004. DOI: 10.1097/DAD.0000000000000058.
［8］	Tsuruta D, Ishii N, Hamada T, et al. IgA pemphigus［J］. Clin Dermatol, 2011, 29（4）: 437⁃442. DOI: 10.1016/j.clindermatol.2011. 01.014.
［9］	van der Steen LP, Bakema JE, Sesarman A, et al. Blocking Fc Receptor I on Granulocytes Prevents Tissue Damage Induced by IgA Autoantibodies［J］. J Immunol, 2012, 189（4）: 1594⁃1601. DOI: 10.4049/jimmunol.1101763.
［10］	Egan CA, Martineau MR, Taylor TB, et al. IgA antibodies recog⁃nizing LABD97 are predominantly IgA1 subclass［J］. Acta Derm Venereol, 1999, 79（5）: 343⁃346. DOI: 10.1080/000155599750010229.
［11］	Bolotin D, Petronic⁃Rosic V. Dermatitis herpetiformis［J］. J Am Acad Dermatol, 2011, 64（6）: 1027⁃1033. DOI: 10.1016/j.jaad.2010. 09.776.
［12］	Dvorak AM, Mihm MJ, Osage JE, et al. Bullous pemphigoid, an ultrastructural study of the inflammatory response: eosinophil, basophil and mast cell granule changes in multiple biopsies from one patient［J］. J Invest Dermatol, 1982, 78（2）: 91⁃101. DOI: 10. 1111/1523⁃1747.ep12505711.
［13］	Nishioka K, Hashimoto K, Katayama I, et al. Eosinophilic spon⁃giosis in bullous pemphigoid［J］. Arch Dermatol, 1984, 120（9）: 1166⁃1168. DOI: 10.1001/archderm.120.9.1166.
［14］	Hurskainen T, Kokkonen N, Sormunen R, et al. Deletion of the major bullous pemphigoid epitope region of collagen ⅩⅦ induces blistering, autoimmunization, and itching in mice［J］. J Invest Dermatol, 2015, 135（5）: 1303⁃1310. DOI: 10.1038/jid.2014. 443.
［15］	Ujiie H. IgE autoantibodies in bullous pemphigoid: Supporting role, or leading player?［J］. J Dermatol Sci, 2015, 78（1）: 5⁃10. DOI: 10.1016/j.jdermsci.2015.03.002.
［16］	Fania L, Caldarola G, Müller R, et al. IgE recognition of bullous pemphigoid （BP）180 and BP230 in BP patients and elderly individuals with pruritic dermatoses［J］. Clin Immunol, 2012, 143（3）: 236⁃245. DOI: 10.1016/j.clim.2012.02.003.
［17］	Moriuchi R, Nishie W, Ujiie H, et al. In vivo analysis of IgE autoantibodies in bullous pemphigoid: a study of 100 cases［J］. J Dermatol Sci, 2015, 78（1）: 21⁃25. DOI: 10.1016/j.jdermsci.2015.01. 013.
［18］	Kamiya K, Aoyama Y, Noda K, et al. Possible correlation of IgE autoantibody to BP180 with disease activity in bullous pemphigoid［J］. J Dermatol Sci, 2015, 78（1）: 77⁃79. DOI: 10.1016/j.jdermsci.2015.02.009.
［19］	Ma L, Wang M, Wang X, et al. Circulating IgE anti⁃BP180 autoantibody and its correlation to clinical and laboratorial aspects in bullous pemphigoid patients［J］. J Dermatol Sci, 2015, 78（1）: 76⁃77. DOI: 10.1016/j.jdermsci.2015.02.015.
［20］	Messingham KN, Pietras TA, Fairley JA. Role of IgE in bullous pemphigoid: a review and rationale for IgE directed therapies［J］. G Ital Dermatol Venereol, 2012, 147（3）: 251⁃257.
［21］	Yu KK, Crew AB, Messingham KA, et al. Omalizumab therapy for bullous pemphigoid［J］. J Am Acad Dermatol, 2014, 71（3）: 468⁃474. DOI: 10.1016/j.jaad.2014.04.053.
［22］	Dufour C, Souillet A L, Chaneliere C, et al. Successful management of severe infant bullous pemphigoid with omalizumab［J］. Br J Dermatol, 2012, 166（5）: 1140⁃1142. DOI: 10.1111/j.1365⁃2133. 2011.10748.x.
［23］	Diaz LA, Prisayanh PS, Dasher DA, et al. The IgM anti⁃desmoglein 1 response distinguishes Brazilian pemphigus foliaceus （fogo selvagem） from other forms of pemphigus［J］. J Invest Dermatol, 2008, 128（3）: 667⁃675. DOI: 10.1038/sj.jid.5701121.
［24］	Velthuis PJ, de Jong MC, Kruis MH. Is there a linear IgM dermatosis? significance of linear IgM junctional staining in cutaneous immunopathology［J］. Acta Derm Venereol, 1988, 68（1）: 8⁃14.
［25］	Arbache ST, Nogueira TG, Delgado L, et al. Immunofluorescence testing in the diagnosis of autoimmune blistering diseases: overview of 10⁃year experience［J］. An Bras Dermatol, 2014, 89（6）: 885⁃889. DOI: 10.1590/abd1806⁃4841.20143221.
［26］	le Roux⁃Villet C, Prost⁃Squarcioni C, Sassolas B, et al. IgM bullous disease associated with IgM gammopathy: a report of two cases and review［J］. Br J Dermatol, 2004, 150（2）: 392⁃394. DOI: 10.1111/j.1365⁃2133.2003.05806.x.

Immunoglobulins in autoimmune bullous diseases

PDF

Like

Knowledge

Abstract

Cite this article

share this article

References ［26］

Related Articles 0

Metrics

Comments

Recommended 10